INSMED INC Debt Securities, Available-for-sale
INSMED INC (INSM) had Debt Securities, Available-for-sale of $615.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale $615.50M.
- 2026-03-31: Debt Securities, Available-for-sale $641.30M.
- 2025-12-31: Debt Securities, Available-for-sale $919.60M.
- 2025-09-30: Debt Securities, Available-for-sale $1.35B.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $615.50M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $641.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $919.60M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.35B 10-Q · filed 2025-10-30 |
| 2025-06-30 | $572.40M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $796.20M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $878.80M 10-K · filed 2025-02-20 |
| 2024-09-30 | $1.00B 10-Q · filed 2024-10-31 |
| 2023-12-31 | $298.10M 10-K · filed 2024-02-22 |
| 2022-12-31 | $74.20M 10-K · filed 2023-02-23 |
| 2021-12-31 | $50.04M 10-K · filed 2022-02-17 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |